Clinical trial
Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for…
NCT00195871 · Centre Henri Becquerel, Other · Unknown status
Key facts
| NCT number | NCT00195871 |
|---|---|
| Title | Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma |
| Official title | A Multicenter, Phase 2 Study, to Evaluate Safety and Efficacy of an Acute Lymphoblastic Leukemia (ALL) Intensive Chemotherapy for Adult Lymphoblastic Lymphoma (LL). |
| Lead sponsor | Centre Henri Becquerel, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoblastic Lymphoma |
| Intervention type | Drug, Procedure |
| Interventions | Prednisone, vincristine, daunorubicin, cyclophosphamide, L.-asparaginase, cytosine-arabinoside, methotrexate, etoposide, hematopoietic stem cell allograft |
| Enrollment | 155 |
| Start date | Feb 1, 2004 |
| Primary completion | Jun 1, 2014 |
| Completion | Dec 1, 2015 |
| First posted | Sep 20, 2005 |
| Last update posted | Nov 7, 2013 |
| Countries | Belgium, France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: